In Vitro Efficacy of Curcumin-Loaded Amine-Functionalized Mesoporous Silica Nanoparticles against MCF-7 Breast Cancer Cells

Zahra Mohebian ¹, Mirzaagha Babazadeh ¹, Nosratollah Zarghami ² *

Cited by CrossRef: 6

1- Ochoa-Sanchez A, Sahare P, Pathak S, Banerjee A, Estevez M, Duttaroy A, Luna-Bárcenas G, Paul S. Evaluation of the synergistic effects of curcumin-resveratrol co-loaded biogenic silica on colorectal cancer cells. Front Pharmacol. 2024;15 [Crossref]

2- Aykaç A, Ok İ, Bakay E, Topaloğlu N. Chitosan-based hydrogel incorporating mesoporous silica/zinc oxide nanoparticles with controlled swelling and potent antibacterial activity. International Journal of Polymeric Materials and Polymeric Biomaterials. 2024;:1 [Crossref]

3- Vieira I, Tessaro L, Lima A, Velloso I, Conte-Junior C. Recent Progress in Nanotechnology Improving the Therapeutic Potential of Polyphenols for Cancer. Nutrients. 2023;15(14):3136 [Crossref]

4- Rostami N, Ghebleh A, Noei H, Rizi Z, Moeinzadeh A, Nikzad A, Gomari M, Uversky V, Tarighi P. Peptide-functionalized polymeric nanoparticles for delivery of curcumin to cancer cells. Journal of Drug Delivery Science and Technology. 2024;102:106337 [Crossref]

5- Zhao Y, Xue Y, Wang C, Zhao Z, Cui R, Zhu B. Antibacterial poly(ethyl methacrylate) surfaces constructed by facile amination with polyethyleneimine of different architectures. Colloids and Surfaces B: Biointerfaces. 2024;:114458 [Crossref]

6- Guan C, Han Y, Ling Z, Meng X, Zhang B, Dong W, Zhang D, Chen K. Nanomaterials: breaking the bottleneck of breast cancer drug resistance. Front Immunol. 2024;15 [Crossref]

7- Nishal S, Kumar V, Phaugat P, Kumar D, Khatri N, Singh G. A Systematic Review and Meta-Analysis of the Metal Nano-Particles Loaded with Herbal Drugs Moieties Against Breast Cancer. NANOTEC. 2025;19(1):120 [Crossref]

8- Rahman M, Afzal O, Ullah S, Alshahrani M, Alkhathami A, Altamimi A, Almujri S, Almalki W, Shorog E, Alossaimi M, Mandal A, abdulrahman A, Sahoo A. Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges. ACS Omega. 2023;8(51):48625 [Crossref]